Tarsus Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
All right, I think we're ready to get started. Good afternoon, everyone. Welcome to the Barclays Miami Healthcare Conference. I'm Jenna Davener. I'm one of the analysts here on the specialty pharmaceuticals team, and I'm very pleased to have Tarsus Pharmaceuticals. On the stage with me this afternoon from the company we have Jeff Barrow, the CFO, and Dave Ncasoni, who's the head of investor relations.
Thank you both for taking the time.
Well, thank you, Jenna. It's great to be here.
So Just.
To Level set the conversation.
The company is a couple years into the launch of Xtdevi, so maybe for people that are newer to the story, can you give us an overview of Tarsus and maybe talk about the timeline of when Xdemvi was approved and launched, and I'm going to get into a couple questions about the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
